Alterations of renal sodium handling in arterial hypertension Michel Burnier Invited Commentary 27 April 2008 Pages: 85 - 86
Prevention of diabetes and left ventricular hypertrophy with AT1 receptor blockade fo hypertension Robert M. Carey Clinical Trials Report 27 April 2008 Pages: 91 - 92
Local adipose tissue renin-angiotensin system Lisa A. CassisSara B. PoliceSean E. Thatcher OriginalPaper 27 April 2008 Pages: 93 - 98
The role of the renin-angiotensin system in aortic aneurysmal diseases Hong LuDebra L. RateriAlan Daugherty OriginalPaper 27 April 2008 Pages: 99 - 106
Arterial structure and function in end-stage renal disease Alain P. GuérinBruno PannierGérard M. London OriginalPaper 27 April 2008 Pages: 107 - 111
Circulating versus tissue renin-angiotensin system: On the origin of (pro)renin Manne KropA. H. Jan Danser OriginalPaper 27 April 2008 Pages: 112 - 118
Ambulatory blood pressure and cardiovascular risk in chronic kidney disease Paolo Palatini OriginalPaper 27 April 2008 Pages: 119 - 126
Treatment strategies for obesity-related hypertension Efrain Reisin Clinical Trials Report 27 April 2008 Pages: 129 - 130
Leptin: Linking obesity, the metabolic syndrome, and cardiovascular disease Sanjeev B. PatelGarry P. ReamsDaniel Villarreal OriginalPaper 27 April 2008 Pages: 131 - 137
New aspects of the relationship among hypertension, obesity, and the kidneys Anja SachseGunter Wolf OriginalPaper 27 April 2008 Pages: 138 - 142
The treatment of hypertension in obese patients Marion R. WoffordGrant SmithDeborah S. Minor OriginalPaper 27 April 2008 Pages: 143 - 150
Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension Edward D. FrohlichDinko Susic OriginalPaper 27 April 2008 Pages: 151 - 155
The link between abdominal obesity and the metabolic syndrome Liza K. PhillipsJohannes B. Prins OriginalPaper 27 April 2008 Pages: 156 - 164